You are here:Home-Chemical Inhibitors & Agonists-GPCR-Glucagon Receptor-GCGR-IN-17
GCGR-IN-17

Chemical Structure : GCGR-IN-17

CAS No.: 1393124-08-7

GCGR-IN-17 (PF-06291874;PF06291874;PF-6291874)

Catalog No.: PC-45758Not For Human Use, Lab Use Only.

PF06291874 (GCGR-IN-17) is a highly potent glucagon receptor antagonist with Ki of 14 nM for hGCGR.

Packing Price Stock Quantity
5 mg $198 In stock
25 mg $398 In stock
100 mg $898 In stock
500 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

PF06291874 (GCGR-IN-17) is a highly potent glucagon receptor antagonist with Ki of 14 nM for hGCGR.
PF06291874 shows excellent selectivity against a panel of 69 receptors, ion channels, uptake sites and enzymes.
PF06291874 reduces the glucagon-elicited glucose excursion in a dose-dep endent manner in rats.
PF06291874 displays low in vivo clearance and excellent oral bioavailability in both rats and dogs.

Physicochemical Properties

M.Wt 503.5134
Formula C26H28F3N3O4
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

DMSO: ≥ 30 mg/mL

Chemical Name/SMILES

glucagon receptor antagonists-4, N-[4-[(1S)-1-[3,5-dimethyl-4-[4-(trifluoromethyl)-1H-pyrazol-1-yl]phenoxy]butyl]benzoyl]-

References

1. Guzman-Perez A, et la. Bioorg Med Chem Lett. 2013 May 15;23(10):3051-8.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: